Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

WBR XPRESS PET

K-Number: K103710 · 2011-01-19

Decision Date2011-01-19
Product CodeKPS
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

WBR XPRESS PET is the device name listed in this FDA 510(k) record. The listed applicant is Ultraspect , Ltd.. It received FDA 510(k) clearance on 2011-01-19 under 510(k) number K103710. The device is classified under product code KPS. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the WBR XPRESS PET?

WBR XPRESS PET is a medical device that received FDA 510(k) clearance on 2011-01-19. The listed applicant is Ultraspect , Ltd.. The 510(k) number is K103710.

When did WBR XPRESS PET receive FDA 510(k) clearance?

WBR XPRESS PET received FDA 510(k) clearance on 2011-01-19, under 510(k) number K103710.

Who is the listed applicant for WBR XPRESS PET?

The FDA 510(k) record lists Ultraspect , Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for WBR XPRESS PET?

The FDA product code for WBR XPRESS PET is KPS.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Ultraspect , Ltd. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: KPS)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑